156 related articles for article (PubMed ID: 37782282)
1. The prevalence of anemia in people with chronic kidney disease after hematopoietic stem cell transplantation.
Kępska-Dzilińska M; Karakulska-Prystupiuk E; Kaszyńska A; Basak GW; Małyszko J
Ren Fail; 2023; 45(2):2263581. PubMed ID: 37782282
[TBL] [Abstract][Full Text] [Related]
2. Anemia in Patients After Stem Cell Transplantation and in Kidney Transplant Recipients.
Kaszyńska A; Kępska-Dzilińska M; Karakulska-Prystupiuk E; Wojtaszek E; Basak G; Nazarewski S; Galązka Z; Malyszko J
Transplant Proc; 2024 May; ():. PubMed ID: 38705734
[TBL] [Abstract][Full Text] [Related]
3. Chronic Kidney Disease in Patients After Allogeneic Hematopoietic Cell Transplant.
Kępska-Dzilińska M; Chomicka I; Karakulska-Prystupiuk E; Tomaszewska A; Basak GW; Malyszko J
Transplant Proc; 2022 May; 54(4):1137-1140. PubMed ID: 35282886
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
Lugthart G; Jordans CCE; de Pagter APJ; Bresters D; Jol-van der Zijde CM; Bense JE; van Rooij-Kouwenhoven RWG; Sukhai RN; Louwerens M; Dorresteijn EM; Lankester AC
Kidney Int; 2021 Oct; 100(4):906-914. PubMed ID: 34102218
[TBL] [Abstract][Full Text] [Related]
5. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
Song X; Qi J; Li X; Zhou M; He J; Chu T; Han Y
Platelets; 2023 Dec; 34(1):2229905. PubMed ID: 37409458
[TBL] [Abstract][Full Text] [Related]
6. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M; Nakayama K; Yamaguchi H; Mii A; Shimizu A; Inai K; Onai D; Marumo A; Omori I; Yamanaka S; Fujiwara Y; Fukunaga K; Ryotokuji T; Hirakawa T; Okabe M; Tamai H; Okamoto M; Wakita S; Yui S; Tsuruoka S; Inokuchi K
Acta Haematol; 2020; 143(5):452-464. PubMed ID: 31822013
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
Jo T; Arai Y; Kondo T; Kitano T; Hishizawa M; Yamashita K; Takaori-Kondo A
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2159-2165. PubMed ID: 28822830
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.
Wu Q; Li X; Lai Y; Peng Z; Liao Y
Int Urol Nephrol; 2014 Jul; 46(7):1403-10. PubMed ID: 24668138
[TBL] [Abstract][Full Text] [Related]
11. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
12. Long-term kidney outcomes in children after allogeneic hematopoietic stem cell transplantation assessed with estimated glomerular filtration rate equations, creatinine levels, and cystatin C levels.
Gadashova A; Tunçay SC; Özek G; Hakverdi G; Kansoy S; Kabasakal C; Aksoylar S
J Bras Nefrol; 2023; 45(1):60-66. PubMed ID: 35788616
[TBL] [Abstract][Full Text] [Related]
13. Role of glutathione S-transferase P1 polymorphism in early transplant complications in patients undergoing allogeneic stem cell transplantation.
Saritas H; Suyani E; Güntekin S; Zeynep AŞ; Ergün MA; Çelik B; Sucak GT
J Cancer Res Ther; 2021; 17(2):565-573. PubMed ID: 34121709
[TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD; Jaimes EA; Malyszko J; Perazella MA; Sprangers B; Rosner MH
Clin J Am Soc Nephrol; 2020 Feb; 15(2):289-297. PubMed ID: 31836598
[TBL] [Abstract][Full Text] [Related]
15. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
16. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of CLAE Chemotherapy Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Leukemia].
Tao SD; Song LX; Deng Y; Chen Y; Zhang X; Ding BH; Wang CL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):677-684. PubMed ID: 37356926
[TBL] [Abstract][Full Text] [Related]
18. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anemia in chronic kidney disease in the United States.
Stauffer ME; Fan T
PLoS One; 2014; 9(1):e84943. PubMed ID: 24392162
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
